| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $121.5M | — | +11.2% |
| Cost of Revenue | $28.0M | — | +12.7% |
| Gross Profit | $93.5M | — | +10.7% |
| R&D Expense | $26.9M | — | +16.0% |
| SG&A Expense | $23.9M | — | -4.5% |
| Operating Income | -$5.8M | — | +47.8% |
| Interest Expense | $667K | — | +29.8% |
| Pre-tax Income | -$5.9M | — | +46.1% |
| Income Tax | $411K | — | +77.9% |
| Net Income | -$6.3M | — | +43.5% |
| EPS (Diluted) | -$0.11 | — | +42.1% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $111.6M | +17.2% | +10.6% |
| Accounts Receivable | $69.4M | -31.3% | +7.2% |
| Current Assets | $225.9M | -4.8% | +8.9% |
| Total Assets | $508.6M | -2.8% | +19.8% |
| Current Liabilities | $237.1M | -7.5% | +10.8% |
| Total Liabilities | $293.4M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $25.2M | — | +39.3% |
| Capital Expenditures | $1.1M | — | -19.0% |
| Investing Cash Flow | -$1.1M | — | -178.9% |
| Financing Cash Flow | -$7.8M | — | -55.3% |
| Free Cash Flow | $24.1M | — | +44.0% |
| +17.7% |
| Stockholders' Equity | $215.2M | +5.8% | +22.7% |